How to Play This Massive Biotech Merger

How to Play This Massive Biotech Merger

On Monday's edition of Investor Beat, host Alison Southwick and Motley Fool analysts Matt Koppenheffer and Matt Argersinger dissect the hardest-hitting investing stories of the day.

Biotech giant Amgen announced today that it's acquiring Onyx Pharmaceuticals for $10.4 billion. In our lead story on Investor Beat, the guys discuss the acquisition and take a look at whether M&A in general is good news for investors.

Our analysts also look at four stocks making moves on Monday's market. Qihoo takes off after its latest earnings report shows how bright this rising star in China wants to shine. Facebook reaches new 52-week highs. Tesla Motors is outselling Jaguar, Porsche, and eight other luxury makers in California. And BATS and Direct Edge merge to take on NYSE and NASDAQ.

Finally, the guys each pick a stock on their radar and tell investors why they're keeping a close watch on shares of Tiffany and Bank of Nova Scotia this week.

Bargains of a lifetime are still available in bank stocks, but it's critical to understand what makes the best banks tick. The Motley Fool's new report "Finding the Next Bank Stock Home Run" demystifies the perils of investing in banks and reveals how savvy investors can win. It's completely free -- click here to get started.

The article How to Play This Massive Biotech Merger originally appeared on

Alison Southwick, Matt Koppenheffer, and Matthew Argersinger have no position in any stocks mentioned. The Motley Fool recommends Baidu, Facebook, SINA, Tesla Motors, and The Bank of Nova Scotia and owns shares of Baidu, Facebook, SINA, and Tesla Motors. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.